Half-year report · Q2
2370.TEDINET S100VQZZ
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥405m | 2024-10-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥769m | 2023-10-01 → 2024-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥400m | 2023-10-01 → 2024-03-31 | Standalone | Net sales |
| Operating income | −¥756m | 2024-10-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | −¥659m | 2023-10-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | −¥711m | 2024-10-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.3bn | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥633m | 2023-10-01 → 2024-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥704m | 2024-10-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥633m | 2023-10-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | −¥706m | 2024-10-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥1.3bn | 2023-10-01 → 2024-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥634m | 2023-10-01 → 2024-03-31 | Standalone | Profit loss |
| Total assets | ¥5.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥5.7bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥6.1bn | at 2024-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥509m | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.4bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.2bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.6bn | at 2024-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.4bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2024-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.4bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2023-09-30d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥754m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.3bn | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥573m | 2023-10-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥65m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17m | 2023-10-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | −¥2m | 2024-10-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.5bn | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2023-10-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.67 | 2024-10-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.04 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.55 | 2023-10-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 81.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.1% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 264,729,198 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 264,515,306 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 256,190,306 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥307m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥186,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥186,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥217m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥405m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥405m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥232m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥405m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥405m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | −¥448m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥286m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥166,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥166,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥219m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥400m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥400m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥154m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥400m |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥400m |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | −¥373m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 457
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 4651181000 | JPY |
| Cash and deposits | CurrentQuarterInstant_NonConsolidatedMember | 3351191000 | JPY |
| Short term investment securities | Prior1YearInstant_NonConsolidatedMember | - | JPY |
| Short term investment securities | CurrentQuarterInstant_NonConsolidatedMember | 500000000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 227801000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant_NonConsolidatedMember | 301650000 | JPY |
| Merchandise and finished goods | Prior1YearInstant_NonConsolidatedMember | - | JPY |
| Merchandise and finished goods | CurrentQuarterInstant_NonConsolidatedMember | 309000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 18684000 | JPY |
| Work in process | CurrentQuarterInstant_NonConsolidatedMember | 29506000 | JPY |
| Raw materials and supplies | Prior1YearInstant_NonConsolidatedMember | 31473000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant_NonConsolidatedMember | 28794000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 83935000 | JPY |
| Other ca | CurrentQuarterInstant_NonConsolidatedMember | 585267000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 5013076000 | JPY |
| Current assets | CurrentQuarterInstant_NonConsolidatedMember | 4796719000 | JPY |
| Buildings net | Prior1YearInstant_NonConsolidatedMember | 340610000 | JPY |
| Buildings net | CurrentQuarterInstant_NonConsolidatedMember | 312037000 | JPY |
| Other net ppe | Prior1YearInstant_NonConsolidatedMember | 82073000 | JPY |
| Other net ppe | CurrentQuarterInstant_NonConsolidatedMember | 79647000 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 422683000 | JPY |
| Property plant and equipment | CurrentQuarterInstant_NonConsolidatedMember | 391685000 | JPY |
| Intangible assets | Prior1YearInstant_NonConsolidatedMember | 100761000 | JPY |
| Intangible assets | CurrentQuarterInstant_NonConsolidatedMember | 93417000 | JPY |
| Investment securities | Prior1YearInstant_NonConsolidatedMember | 101522000 | JPY |
| Investment securities | CurrentQuarterInstant_NonConsolidatedMember | 91521000 | JPY |
| Long term loans receivable | Prior1YearInstant_NonConsolidatedMember | 495250000 | JPY |
| Long term loans receivable | CurrentQuarterInstant_NonConsolidatedMember | 492750000 | JPY |
| Other ioa | Prior1YearInstant_NonConsolidatedMember | 86466000 | JPY |
| Other ioa | CurrentQuarterInstant_NonConsolidatedMember | 87853000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant_NonConsolidatedMember | -519728000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant_NonConsolidatedMember | -516628000 | JPY |
| Investments and other assets | Prior1YearInstant_NonConsolidatedMember | 163509000 | JPY |
| Investments and other assets | CurrentQuarterInstant_NonConsolidatedMember | 155495000 | JPY |
| Noncurrent assets | Prior1YearInstant_NonConsolidatedMember | 686955000 | JPY |
| Noncurrent assets | CurrentQuarterInstant_NonConsolidatedMember | 640598000 | JPY |
| Assets | Prior1YearInstant_NonConsolidatedMember | 5700031000 | JPY |
| Assets | CurrentQuarterInstant_NonConsolidatedMember | 5437318000 | JPY |
| Accounts payable trade | Prior1YearInstant_NonConsolidatedMember | 57502000 | JPY |
| Accounts payable trade | CurrentQuarterInstant_NonConsolidatedMember | 54326000 | JPY |
| Accounts payable other | Prior1YearInstant_NonConsolidatedMember | 97284000 | JPY |
| Accounts payable other | CurrentQuarterInstant_NonConsolidatedMember | 579591000 | JPY |
| Income taxes payable | Prior1YearInstant_NonConsolidatedMember | 28654000 | JPY |
| Income taxes payable | CurrentQuarterInstant_NonConsolidatedMember | 15508000 | JPY |
| Provision for bonuses | Prior1YearInstant_NonConsolidatedMember | 67604000 | JPY |
| Provision for bonuses | CurrentQuarterInstant_NonConsolidatedMember | 66141000 | JPY |
| Other cl | Prior1YearInstant_NonConsolidatedMember | 17876000 | JPY |
| Other cl | CurrentQuarterInstant_NonConsolidatedMember | 57129000 | JPY |
| Current liabilities | Prior1YearInstant_NonConsolidatedMember | 268922000 | JPY |
| Current liabilities | CurrentQuarterInstant_NonConsolidatedMember | 772697000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |